一种口服的基因编辑纳米粒子增强了结直肠癌的化疗免疫疗法
Kai Zhao1, Yu Yan1, Xiao-Kang Jin1
1Key Laboratory of Biomedical Polymers of Ministry of Education and Department of Chemistry, Wuhan University, Wuhan, P. R. China.
Nature nanotechnology
|April 24, 2025
概括
研究人员开发了一种口服CRISPR-Cas9系统,以破坏结直肠癌 (CRC) 中的TRAP1基因. 这种方法克服了化学抵抗并增强了抗瘤免疫反应,为CRC患者提供了有前途的新疗法.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 基因治疗 基因治疗
背景情况:
- 化疗抵抗和免疫抑制阻碍了结直肠癌 (CRC) 中的化疗免疫疗法的有效性.
- 包括TRAP1在内的线粒体伴侣蛋白调节这些障碍.
- 瘤细胞中TRAP1的破坏会影响线粒体功能和免疫反应.
研究的目的:
- 调查TRAP1在CRC中化学抵抗和免疫抑制中的作用.
- 开发一种新的口服CRISPR-Cas9传递系统,针对CRC中的TRAP1.
- 在临床前CRC模型中评估该系统的治疗潜力.
主要方法:
- 在CRC细胞中破坏瘤亡因子受体相关蛋白1 (TRAP1) 基因.
- 开发一种口服CRISPR-Cas9输送系统,使用采和多糖聚合物涂层纳米复合物.
- 评估系统透肠道粘液层并经历上皮细胞转细胞化的能力.
- 评估系统在正位体,化学耐药和自发CRC模型中的有效性.
主要成果:
- 破坏TRAP1基因导致循环林D转位和线粒体透性过渡孔的持续开放.
- 这一过程增强了化疗诱导的细胞亡,并促进了抗瘤免疫反应.
- 口服CRISPR-Cas9系统有效地向CRC组织,克服化学抵抗并激活瘤免疫微环境.
- 在各种CRC模型中观察到协同作用的抗瘤效应.
结论:
- 在CRC中,TRAP1是化学抵抗和免疫逃避的关键调节者.
- 开发的口服CRISPR-Cas9传递系统有效地破坏CRC中的TRAP1.
- 这种治疗策略显示出提高化疗免疫疗法的有效性和控制结直肠癌的巨大潜力.
相关概念视频
00:59Gene Therapy
24.9K
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
24.9K
01:27Tumor Immunotherapy
398
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
398
02:57Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K